首页> 外文期刊>Progress in retinal and eye research >MRI of rod cell compartment-specific function in disease and treatment in vivo
【24h】

MRI of rod cell compartment-specific function in disease and treatment in vivo

机译:杆状细胞室特异功能在疾病和体内治疗中的MRI

获取原文
获取原文并翻译 | 示例
       

摘要

Rod cell oxidative stress is a major pathogenic factor in retinal disease, such as diabetic retinopathy (DR) and retinitis pigmentosa (RP). Personalized, non-destructive, and targeted treatment for these diseases remains elusive since current imaging methods cannot analytically measure treatment efficacy against rod cell compartment-specific oxidative stress in vivo. Over the last decade, novel MRI-based approaches that address this technology gap have been developed. This review summarizes progress in the development of MRI since 2006 that enables earlier evaluation of the impact of disease on rod cell compartment-specific function and the efficacy of anti-oxidant treatment than is currently possible with other methods. Most of the new assays of rod cell compartment-specific function are based on endogenous contrast mechanisms, and this is expected to facilitate their translation into patients with DR and RP, and other oxidative stress-based retinal diseases. (C) 2015 Published by Elsevier Ltd.
机译:杆状细胞氧化应激是视网膜疾病的主要致病因素,例如糖尿病性视网膜病(DR)和色素性视网膜炎(RP)。这些疾病的个性化,非破坏性和靶向治疗仍然难以捉摸,因为当前的成像方法无法分析性地衡量针对杆状细胞区室特异性氧化应激的体内治疗效果。在过去的十年中,已经开发出了基于MRI的新颖方法来解决这一技术空白。这篇综述总结了自2006年以来MRI发展的进展,该进展使疾病对杆细胞室特异性功能的影响和抗氧化剂治疗的功效得以比其他方法更早地评估。杆细胞区室特异性功能的大多数新测定法均基于内源性对比机制,这有望促进其转化为DR和RP以及其他基于氧化应激的视网膜疾病的患者。 (C)2015由Elsevier Ltd.出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号